PDA Metro: Supply Chain

Program Highlights

Abstract

The Impact of COVID 19 on Supply Chain

Supply Chain planning requires a sharper focus on Business Continuity planning and Supplier Management program adaptability for COVID-era procurement of drug substance/drug product ingredients, components, storage, and transportation.  Life science organizations must address balancing supply and demand in a highly volatile market made more complex by COVID-19. 

This presentation will review the history of Supply Chain (and its journey from stock on hand to just-in-time and possibly back to stock on hand), take a look at COVID-sparked legislation that may impact Supply Chain in the future, identify current strategies for Supply Chain optimization and resiliency, and consider whether COVID 19 has changed Supply Chain forever.

Speaker

Kelly Smeltzer Bio

Kelly currently serves as a Principal Consultant for CAI, Inc.  As a Principal Consultant, Kelly provides CAI clients with guidance on multiple areas of biopharmaceutical manufacturing, specializing in Quality Management Systems and Supply Chain Management.  Kelly was the Logistics Lead on a project to construct the fourth largest gamma irradiator in the world in Albuquerque, NM.  She is a member of ASCM and ASQ and has over 35 years’ experience in pharmaceutical and device manufacturing.  Kelly holds a Masters’ degree in Liberal Arts and is Lean Six Sigma and Six Sigma Greenbelt certified from Villanova University.